X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (49) 49
oncology (40) 40
humans (35) 35
female (22) 22
male (22) 22
middle aged (19) 19
mutation (19) 19
protein kinase inhibitors - therapeutic use (15) 15
cancer (14) 14
aged (13) 13
carcinoma, non-small-cell lung - drug therapy (13) 13
carcinoma, non-small-cell lung - genetics (12) 12
lung neoplasms - genetics (12) 12
lung neoplasms - pathology (12) 12
respiratory system (12) 12
adult (11) 11
carcinoma, non-small-cell lung - pathology (11) 11
immunotherapy (11) 11
lung neoplasms - drug therapy (11) 11
cell lung-cancer (10) 10
crizotinib (10) 10
chemotherapy (9) 9
resistance (9) 9
antineoplastic agents - therapeutic use (8) 8
hematology, oncology and palliative medicine (8) 8
lung cancer, non-small cell (8) 8
open-label (8) 8
adenocarcinoma (7) 7
alectinib (7) 7
article (7) 7
gastric cancer (7) 7
neoplasm staging (7) 7
nsclc (7) 7
prognosis (7) 7
pyridines - therapeutic use (7) 7
acquired-resistance (6) 6
adenocarcinoma - pathology (6) 6
care and treatment (6) 6
disease progression (6) 6
gastroenterology & hepatology (6) 6
genomic profiling (6) 6
lung cancer (6) 6
pulmonary/respiratory (6) 6
pyrazoles - therapeutic use (6) 6
receptor protein-tyrosine kinases - genetics (6) 6
review (6) 6
tumors (6) 6
tyrosine kinase inhibitor (6) 6
biopsy (5) 5
brain neoplasms - drug therapy (5) 5
brain neoplasms - secondary (5) 5
comprehensive genomic profiling (5) 5
double-blind (5) 5
genetic aspects (5) 5
medical colleges (5) 5
molecular targeted therapy (5) 5
neoplasms. tumors. oncology. including cancer and carcinogens (5) 5
next-generation sequencing (5) 5
radiation (5) 5
targeted therapy (5) 5
treatment outcome (5) 5
biomarkers, tumor - genetics (4) 4
cancer therapies (4) 4
carcinoma (4) 4
drug resistance, neoplasm - genetics (4) 4
gastrointestinal cancer (4) 4
gene expression regulation, neoplastic (4) 4
genomics - methods (4) 4
heterogeneity (4) 4
high-throughput nucleotide sequencing (4) 4
lung neoplasms - metabolism (4) 4
metastasis (4) 4
mutation - genetics (4) 4
mutations (4) 4
patients (4) 4
pembrolizumab (4) 4
receptor protein-tyrosine kinases - metabolism (4) 4
stomach cancer (4) 4
survival (4) 4
therapy (4) 4
tumor mutational burden (4) 4
adenocarcinoma - genetics (3) 3
anaplastic lymphoma kinase (3) 3
biomarker (3) 3
brain metastases (3) 3
breast-cancer (3) 3
cancer patients (3) 3
carbazoles - therapeutic use (3) 3
carcinoma, non-small-cell lung - enzymology (3) 3
ceritinib (3) 3
circulating tumor dna (3) 3
colon cancer (3) 3
colorectal cancer (3) 3
crizotinib resistance (3) 3
development and progression (3) 3
dna mutational analysis (3) 3
drug resistance, neoplasm (3) 3
egfr (3) 3
epidermal growth factor (3) 3
esophageal cancer (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lung Cancer, ISSN 0169-5002, 2016, Volume 96, pp. 15 - 18
Journal Article
International Neurourology Journal, ISSN 2093-4777, 2016, Volume 20, Issue Suppl 2, pp. 131 - 140
Phosphatidylinositol-3-kinase (PI3K) pathway signaling is an established oncogenic signal transduction pathway implicated in multiple malignancies. Therapeutic... 
Molecular Targeted Therapies | Clinical Trial | MTOR protein | Stomach Neoplasms | AKT oncogene protein | PIK3CA portein | RESISTANCE MECHANISMS | PERIOPERATIVE CHEMOTHERAPY | PIK3CA MUTATIONS | GASTROESOPHAGEAL JUNCTION | INHIBITOR EVEROLIMUS RAD001 | PHASE-II | PI3K INHIBITION | mTOR protein | BIOMARKER DEVELOPMENT | MTOR INHIBITION | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | Review
Journal Article
Journal Article
Journal of Gastrointestinal Oncology, ISSN 2078-6891, 08/2018, Volume 9, Issue 4, pp. 610 - 617
Background: The clinical application of PD1/PD-L1 targeting checkpoint inhibitors in colorectal cancer (CRC) has largely focused on a subset of microsatellite... 
Tumor mutational burden | Microsatellite instability | PD-1 | Immunotherapy | Colorectal cancer | microsatellite instability | FIRE-3 | colorectal cancer | INSTABILITY | STATISTICS | LANDSCAPE | LOAD | PD-1 BLOCKADE | SENSITIVITY | ONCOLOGY | tumor mutational burden | immunotherapy | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Original
Journal Article
Molecular Oncology, ISSN 1574-7891, 10/2015, Volume 9, Issue 8, pp. 1694 - 1703
Journal Article
Journal of Gastrointestinal Oncology, ISSN 2078-6891, 06/2018, Volume 9, Issue 3, pp. 560 - 572
The multidisciplinary management of locoregional esophagogastric cancers (GCs) has evolved significantly over the past two decades. While perioperative... 
Neoadjuvant | Adjuvant | FLOT | The Cancer Genome Atlas (TCGA) | Immunotherapy | Gastric cancer (GC) | LYMPH-NODE DISSECTION | ADJUVANT CHEMOTHERAPY | SURGERY | PERIOPERATIVE CHEMOTHERAPY | PLUS CISPLATIN | neoadjuvant | RANDOMIZED-TRIAL | OPEN-LABEL | PHASE-III TRIAL | ONCOLOGY | adjuvant | GASTRIC-CANCER | immunotherapy | D2 GASTRECTOMY | GASTROENTEROLOGY & HEPATOLOGY | Review
Journal Article
Translational Cancer Research, ISSN 2218-676X, 2016, Volume 5, pp. S25 - S30
Journal Article
Gastrointestinal cancer : targets and therapy, ISSN 1179-9919, 2017, Volume 7, pp. 1 - 11
Gastric adenocarcinoma is a leading cause of global cancer-related morbidity and mortality, and new therapeutic approaches are needed. Despite the improved... 
Usage | Endothelial growth factors | Mortality | Analysis | Immunotherapy | Physiological aspects | Causes of | Monoclonal antibodies | Research | Stomach cancer | Health aspects | Human papillomavirus | Mutation | Kinases | Cancer therapies | pembrolizumab | stomach cancer | nivolumab | tumor mutational burden | immunotherapy | checkpoint inhibitor | gastric cancer | PD-1
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2015, Volume 4, Issue 5, pp. 649 - 652
The increasing appreciation of oncogenic driver alterations in non-small cell lung cancer (NSCLC) has resulted in a rapid expansion of therapeutic compounds.... 
Crizotinib | Alectinib | Targeted therapy | Lung cancer | Ceritinib | Anaplastic lymphoma kinase (ALK) | lung cancer | targeted therapy | ceritinib | anaplastic lymphoma kinase (ALK) | alectinib
Journal Article
The Journal of Alternative and Complementary Medicine, ISSN 1075-5535, 08/2013, Volume 19, Issue 8, pp. 729 - 731
Journal Article
Journal of Gastrointestinal Oncology, ISSN 2078-6891, 12/2018, Volume 9, Issue 6, pp. 1198 - 1206
Background: Gastric cancer (GC) is a leading cause of cancer-specific mortality with limited biologically informed treatments. The ataxia telangiectasia... 
PARP | Platinum | Ataxia telangiectasia mutated (ATM) | Stomach cancer | DNA damage | DNA-DAMAGE | OPEN-LABEL | OVARIAN-CANCER | BRCA1 | GASTROESOPHAGEAL JUNCTION CANCER | OLAPARIB | platinum | ONCOLOGY | ataxia telangiectasia mutated (ATM) | PROTEIN EXPRESSION | DOUBLE-BLIND | IONIZING-RADIATION | GASTROENTEROLOGY & HEPATOLOGY | Original
Journal Article
JAMA NETWORK OPEN, ISSN 2574-3805, 05/2019, Volume 2, Issue 5, p. e192546
Journal Article